Ticker to stay NSPR TEL AVIV, Israel, May well 10, 2021 (World NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Avoidance System (EPS) for the avoidance of stroke caused by the remedy of Carotid Artery Disease (CAD), currently announced the Company’s shares have been authorised for […]